1.24
前日終値:
$1.34
開ける:
$1.33
24時間の取引高:
4.41M
Relative Volume:
0.97
時価総額:
$362.46M
収益:
-
当期純損益:
$-63.08M
株価収益率:
-4.5926
EPS:
-0.27
ネットキャッシュフロー:
$-72.53M
1週間 パフォーマンス:
-10.14%
1か月 パフォーマンス:
-22.50%
6か月 パフォーマンス:
+76.51%
1年 パフォーマンス:
+29.42%
Ocugen Inc Stock (OCGN) Company Profile
OCGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OCGN
Ocugen Inc
|
1.24 | 418.51M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-15 | 開始されました | Maxim Group | Buy |
| 2023-03-01 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 開始されました | Mizuho | Buy |
| 2022-06-15 | 再開されました | ROTH Capital | Buy |
| 2022-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 開始されました | Noble Capital Markets | Outperform |
| 2021-06-11 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
すべてを表示
Ocugen Inc (OCGN) 最新ニュース
How Ocugen Inc. (2H51) stock compares with tech leadersRate Hike & Growth Oriented Trading Recommendations - newser.com
Key resistance and support levels for Ocugen Inc.July 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Is Ocugen Inc. showing signs of accumulationTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Is Ocugen Inc. stock resilient to inflationMarket Growth Summary & Fast Gain Swing Trade Alerts - newser.com
Price momentum metrics for Ocugen Inc. explainedWall Street Watch & Risk Managed Investment Signals - newser.com
Combining price and volume data for Ocugen Inc.Quarterly Trade Report & Fast Moving Stock Watchlists - newser.com
How high can Ocugen Inc. stock goJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Is Ocugen Inc. still worth holding after the dipTrend Reversal & Weekly High Conviction Ideas - newser.com
Identifying reversal signals in Ocugen Inc.Weekly Stock Analysis & Community Verified Trade Signals - newser.com
Is Ocugen Inc. (2H51) stock a top dividend aristocrat candidateJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Is Ocugen Inc. stock a safe investment in uncertain marketsWeekly Loss Report & Weekly High Return Forecasts - newser.com
Ocugen Advances Gene Therapy Pipeline as Phase 3 Trials Near Key Milestones - MyChesCo
Using economic indicators to assess Ocugen Inc. potentialPortfolio Return Summary & Low Risk Growth Stock Ideas - newser.com
Ocugen (OCGN) Is Down 7.0% After Mixed Q3 Results and Gene Therapy Milestones – What's Changed - simplywall.st
Ocugen (OCGN) Sees Higher Revenue but Wider Losses Is Funding the Pipeline a Growing Challenge? - Yahoo Finance
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
How Ocugen Inc. (2H51) stock trades pre earningsRecession Risk & Real-Time Stock Price Movement Reports - newser.com
Will Ocugen Inc. stock outperform tech sector in 2025July 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Is it time to cut losses on Ocugen Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Ocugen Inc. (2H51) stock resilient in recession scenariosSwing Trade & Risk Managed Investment Strategies - newser.com
Will Ocugen Inc. stock maintain dividend yieldFed Meeting & Target Return Focused Stock Picks - newser.com
Ocugen Reports Progress in Gene Therapy Trials Amid Financial Losses - MSN
Why Ocugen Inc. (2H51) stock trades below fair valueWeekly Gains Summary & Community Verified Swing Trade Signals - newser.com
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Ad - GuruFocus
Ocugen Inc (OCGN) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Is Ocugen Inc. stock ready for breakoutDay Trade & Real-Time Market Trend Scan - newser.com
Ocugen Inc (OCGN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):